Donald I. Abrams

Donald I. Abrams, M.D. is a Clinical Professor of Medicine at the University of California San Francisco (UCSF), serving as a general oncologist at Zuckerberg San Francisco General Hospital and an integrative oncologist at the UCSF Osher Center for Integrative Medicine. With over four decades of experience, he pioneered research on complementary therapies in HIV/AIDS and cancer care, notably establishing early clinical protocols during the AIDS epidemic and leading landmark studies on medical cannabis.

Education:

• Brown University, AB in Molecular Biology (1972)
• Stanford University School of Medicine, MD (1977)
• Kaiser Foundation Hospital, Internal Medicine Residency (1980)
• UCSF Cancer Research Institute, Hematology-Oncology Fellowship (1983)
• University of Arizona, Fellowship in Integrative Medicine (2004)

Research Focus: Dr. Abrams' work centers on integrative oncology, with special emphasis on nutrition-cancer interactions and cannabinoid therapeutics. His clinical trials have rigorously evaluated medical marijuana for symptom management in HIV and cancer, debunking myths through evidence-based approaches. He champions botanical therapies like medicinal mushrooms while maintaining scientific rigor in complementary medicine research.

Publication Trends: Recent works (2020-2024) demonstrate evolving focus from HIV/cannabis interactions to mainstream oncology applications, including ASCO guidelines on cannabis for cancer patients and biomarker research for autism treatment. While most publications concentrate on medical applications, collaborative physics work appears in nuclear structure studies.

Scientific Recognition:

• American Foundation for AIDS Research Award of Courage (2000)
• International Association for Cannabis as Medicine Clinical Research Award (2007)
• Patients Out of Time Lifetime Achievement Award (2015)
• Newsweek Top Cancer Doctors designation (2015)
• UCSF Sarlo Award for Excellence in Mentoring (2002)

Research Leadership: As Principal Investigator on 7+ NIH grants totaling millions in funding, Dr. Abrams directed pivotal studies including Opioid and Cannabinoid Pharmacokinetic Interactions (R21DA020831) and Antihyperlipidemic Effects of Oyster Mushrooms (R21AT001782). His co-edited Oxford textbook established foundational knowledge in integrative oncology, while his role on the NCI PDQ CAM Editorial Board shapes national treatment standards.

Collaborative Networks: He leads the PRIMIER research registry through BraveNet and maintains active roles in the Society of Integrative Oncology (past President) and UCSF Osher Center, driving translational research from bench to bedside in integrative cancer care.